Lyell Immunopharma, Inc. (LYEL)

21.40 -0.20 (-0.93%) USD  |  NASDAQ  |  Feb 20, 16:00
21.28 -0.12 (-0.54%) After-Hours: 20:00
More

Lyell Immunopharma EBIT (Quarterly)

EBIT (Quarterly) Chart

View EBIT (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (Quarterly) Range, Past 5 Years

View EBIT (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (Quarterly) Benchmarks

View EBIT (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade